Seeking Alpha

Exclusive BAC Article: Zymeworks; GEJAC Data Zanidatamab Q2 Of 2025, Plus Possible BLA 2nd Half 2025, Two Regulatory Decisions On Deck 2025 And Catalysts

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Zymeworks (ZYME). The reason why I want to go over this biotech next is because it has a major ...
Seeking Alpha

Exclusive BAC Article: Immunovant; Batoclimab POC Grave's Disease, Phase 3 Study Readouts IMVT-1402 In 2027, 2026 POC Data ACPA+ RA & CLE And Catalysts

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Immunovant (IMVT). The reason why I want to go over this biotech next is because its lead ...